In a multicenter, double-blind trial, we randomly assigned mechanically ventilated adults with sepsis to receive dexmedetomidine (0.2 to 1.5 μg per kilogram of body weight per hour) or propofol (5 to ...

We report the use of dexmedetomidine infusion in critically ill infants and children at doses of 0.2–0.7 μg/kg/hr for a median duration of 141 hours. The major findings from our study include 1) ...

NEW HAVEN, Conn., Aug. 06, 2025 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence to develop transformative medicines in ...

The administration of dexmedetomidine was associated with reduced perioperative requirements for opioids in pediatric tonsillectomy, along with lower likelihoods of emergence delirium and ...

Please provide your email address to receive an email when new articles are posted on . Dexmedetomidine may be an acceptable sedative to administer during dermatologic and cosmetic surgical procedures ...

Please provide your email address to receive an email when new articles are posted on . At 7 and 42 days postpartum, women who received dexmedetomidine had lower positive postpartum depression rates.

BXCL501 is an oral thin film formulation of dexmedetomidine, a selective alpha-2a receptor agonist. The Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to BXCL501 ...

Learn everything you need to know about Dexmedetomidine-pronunciation, uses, dosage guidelines, indications, and when to take or avoid it. Get up-to-date information on side effects, precautions, ...

NEW HAVEN, Conn., July 16, 2024 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence to develop transformative medicines in ...

Details concerning the Dexmedetomidine medication encompass its pricing as well as its availability in various forms, including tablets, capsules, syrups, creams, gels, ointments, liquids, and ...